1. Home
  2. STRO vs QTRX Comparison

STRO vs QTRX Comparison

Compare STRO & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sutro Biopharma Inc.

STRO

Sutro Biopharma Inc.

HOLD

Current Price

$25.64

Market Cap

338.9M

Sector

Health Care

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.54

Market Cap

306.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
STRO
QTRX
Founded
2003
2007
Country
United States
United States
Employees
131
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
338.9M
306.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
STRO
QTRX
Price
$25.64
$3.54
Analyst Decision
Buy
Hold
Analyst Count
8
2
Target Price
$26.38
$8.00
AVG Volume (30 Days)
159.8K
779.0K
Earning Date
05-07-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
$13.45
$9.82
P/E Ratio
N/A
N/A
Revenue Growth
N/A
64.52
52 Week Low
$0.52
$3.36
52 Week High
$27.96
$8.77

Technical Indicators

Market Signals
Indicator
STRO
QTRX
Relative Strength Index (RSI) 64.10 29.07
Support Level $0.76 $3.36
Resistance Level $27.96 $5.56
Average True Range (ATR) 2.13 0.31
MACD -0.07 0.01
Stochastic Oscillator 90.81 11.15

Price Performance

Historical Comparison
STRO
QTRX

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.

Share on Social Networks: